Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 5/20 | 0.49 |
| ▸ | NAALAD2 | Q9Y3Q0 | 3/20 | 0.49 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.49 |
| ▸ | GRM8 | O00222 | 1/20 | 0.44 |
| ▸ | GRM6 | O15303 | 1/20 | 0.44 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.44 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.44 |
| ▸ | GSR | P00390 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.44 |
| ▸ | GRM5 | P41594 | 1/20 | 0.44 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.44 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.44 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.44 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.44 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.44 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.44 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.44 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30099677 | 0.98 | FOLH1 (0.47) | FOLH1NAALAD2RIMKLAGRM8GRM6 | |
| SCHEMBL30099487 | 0.98 | FOLH1 (0.47) | FOLH1NAALAD2RIMKLAGRM8GRM6 | |
| SCHEMBL31480000 | 0.98 | FOLH1 (0.47) | FOLH1NAALAD2RIMKLAGRM8GRM6 | |
| SCHEMBL30040249 | 0.95 | FOLH1 (0.51) | FOLH1NAALAD2RIMKLAGRM8GRM6 | |
| SCHEMBL29539765 | 0.95 | FOLH1 (0.55) | FOLH1NAALAD2RIMKLAGRM8GRM6 | |
| SCHEMBL30312227 | 0.94 | DPP4 (0.50) | FOLH1NAALAD2RIMKLAGRM8GRM6 | |
| SCHEMBL30040038 | 0.94 | FOLH1 (0.53) | FOLH1NAALAD2RIMKLAGRM8GRM6 | |
| SCHEMBL30193271 | 0.94 | FOLH1 (0.53) | FOLH1NAALAD2RIMKLAGRM8GRM6 | |
| SCHEMBL30193339 | 0.94 | FOLH1 (0.53) | FOLH1NAALAD2RIMKLAGRM8GRM6 | |
| SCHEMBL31479997 | 0.92 | DPP4 (0.49) | FOLH1NAALAD2RIMKLAGRM8GRM6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250123280-A1 | LABEL-FREE DETECTION OF PROTEASE ACTIVITY | UNIV OREGON HEALTH & SCIENCE (US) | 2025-04-17 | — | — | US | claimed |
| US-20220256889-A1 | PEPTIDES THAT MODULATE CALCIUM-SENSING RECEPTOR ACTIVITY FOR MODULATING KOKUMI TASTE AND PET FOOD PRODUCTS CONTAINING THE SAME | MARS, INCORPORATED (US) | 2022-08-18 | — | — | US | claimed |
| US-12569521-B2 | Methods and compositions for treating inflammatory skin disease with recombinant microorganisms | AZITRA INC (US) | 2026-03-10 | — | — | US | disclosed |
| US-20250090599-A1 | METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY SKIN DISEASE WITH RECOMBINANT MICROORGANISMS | AZITRA INC. | 2025-03-20 | — | — | US | disclosed |
| US-12208124-B2 | Methods and compositions for treating inflammatory skin disease with recombinant microorganisms | AZITRA INC. (US) | 2025-01-28 | — | — | US | disclosed |
| CN-118853521-A | Methods and compositions for treating inflammatory skin diseases with recombinant microorganisms | 阿兹特拉公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-111278447-B | Methods and compositions for treating inflammatory skin diseases with recombinant microorganisms | 阿兹特拉公司 | 2024-08-06 | — | — | CN | disclosed |
| WO-2023003984-A2 | LABEL-FREE DETECTION OF PROTEASE ACTIVITY | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2023-01-26 | — | — | WO | disclosed |
| US-20220325072-A1 | ZWITTERIONIC CROSSLINKERS, HYDROGELS COMPRISING ZWITTERIONIC CROSSLINKERS, AND METHODS FOR MAKING AND USING | UNIVERSITY OF IDAHO | 2022-10-13 | — | — | US | disclosed |
| US-20220256889-A1 | PEPTIDES THAT MODULATE CALCIUM-SENSING RECEPTOR ACTIVITY FOR MODULATING KOKUMI TASTE AND PET FOOD PRODUCTS CONTAINING THE SAME | MARS, INCORPORATED (US) | 2022-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12208124-B2 | Methods and compositions for treating inflammatory skin disease with recombinant microorganisms | CUTA, TLR9, CX3CR1 | FOLH1 1806/4885NAALAD2 1291/4885RIMKLA 2104/4885 |
| US-20220325072-A1 | ZWITTERIONIC CROSSLINKERS, HYDROGELS COMPRISING ZWITTERIONIC CROSSLINKERS, AND METHODS FOR MAKING AND USING | ASS1, GFER, ASIC1 | FOLH1 3483/4885NAALAD2 498/4885RIMKLA 202/4885 |
| US-12569521-B2 | Methods and compositions for treating inflammatory skin disease with recombinant microorganisms | CUTA, MAFG, LRBA | FOLH1 667/4885NAALAD2 1596/4885RIMKLA 3178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.